| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2
|
Kralovics, Robert
|
|
|
106 |
10 |
p. 3374-3376
|
article
|
| 2 |
A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis
|
Tome, Margaret E.
|
|
|
106 |
10 |
p. 3594-3601
|
article
|
| 3 |
A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus
|
Glud, Sys Zoffmann
|
|
|
106 |
10 |
p. 3546-3552
|
article
|
| 4 |
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
|
Hill, Deirdre A.
|
|
|
106 |
10 |
p. 3358-3365
|
article
|
| 5 |
CD94 1A/1B: a window opens into NK-cell development
|
Lieto, Louis D.
|
|
|
106 |
10 |
p. 3338-3339
|
article
|
| 6 |
CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features
|
Lin, Chung-Wu
|
|
|
106 |
10 |
p. 3567-3574
|
article
|
| 7 |
CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon–dependent, TRAIL/DR5-mediated apoptosis
|
Herbeuval, Jean-Philippe
|
|
|
106 |
10 |
p. 3524-3531
|
article
|
| 8 |
Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL
|
Moskowitz, Craig H.
|
|
|
106 |
10 |
p. 3383-3385
|
article
|
| 9 |
Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment
|
De Smedt, Magda
|
|
|
106 |
10 |
p. 3498-3506
|
article
|
| 10 |
Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways
|
Salameh, Ahmad
|
|
|
106 |
10 |
p. 3423-3431
|
article
|
| 11 |
Distinct roles for the NF-κB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals
|
O'Keeffe, Meredith
|
|
|
106 |
10 |
p. 3457-3464
|
article
|
| 12 |
Donor origin of multipotent adult progenitor cells in radiation chimeras
|
Reyes, Morayma
|
|
|
106 |
10 |
p. 3646-3649
|
article
|
| 13 |
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-α–refractory adult T-cell leukemia
|
Mone, Andrew
|
|
|
106 |
10 |
p. 3380-3382
|
article
|
| 14 |
Editorial Board
|
|
|
|
106 |
10 |
p. i
|
article
|
| 15 |
Endogenous NGF regulates CGRP expression in human monocytes, and affects HLA-DR and CD86 expression and IL-10 production
|
Bracci-Laudiero, Luisa
|
|
|
106 |
10 |
p. 3507-3514
|
article
|
| 16 |
Evidence for ineffective erythropoiesis in severe sickle cell disease
|
Wu, Catherine J.
|
|
|
106 |
10 |
p. 3639-3645
|
article
|
| 17 |
Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients
|
Leung, Nelson
|
|
|
106 |
10 |
p. 3353-3357
|
article
|
| 18 |
Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3
|
Penna, Giuseppe
|
|
|
106 |
10 |
p. 3490-3497
|
article
|
| 19 |
Factor VIII tolerance: is more better?
|
Lozier, Jay
|
|
|
106 |
10 |
p. 3334
|
article
|
| 20 |
Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency
|
Hanna, Jacob
|
|
|
106 |
10 |
p. 3465-3473
|
article
|
| 21 |
Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing
|
Chen, Leslie Y.
|
|
|
106 |
10 |
p. 3673-3674
|
article
|
| 22 |
Gene therapy: efficient targeting of hematopoietic stem cells
|
Karlsson, Stefan
|
|
|
106 |
10 |
p. 3333
|
article
|
| 23 |
Hematology, ASH, and the anemia of the aged
|
Schrier, Stanley L.
|
|
|
106 |
10 |
p. 3341-3342
|
article
|
| 24 |
Heterogeneity of engrafted bone-lining cells after systemic and local transplantation
|
Wang, Liping
|
|
|
106 |
10 |
p. 3650-3657
|
article
|
| 25 |
High-dose factor VIII inhibits factor VIII–specific memory B cells in hemophilia A with factor VIII inhibitors
|
Hausl, Christina
|
|
|
106 |
10 |
p. 3415-3422
|
article
|
| 26 |
Immunoglobulin light chain repertoire in chronic lymphocytic leukemia
|
Stamatopoulos, Kostas
|
|
|
106 |
10 |
p. 3575-3583
|
article
|
| 27 |
Induction of HM1.24 peptide–specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma
|
Jalili, Ali
|
|
|
106 |
10 |
p. 3538-3545
|
article
|
| 28 |
In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets
|
Goemans, Bianca F.
|
|
|
106 |
10 |
p. 3532-3537
|
article
|
| 29 |
In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations
|
Silverman, Lee R.
|
|
|
106 |
10 |
p. 3602-3608
|
article
|
| 30 |
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome–negative CML, and megakaryocytic leukemia
|
Jelinek, Jaroslav
|
|
|
106 |
10 |
p. 3370-3373
|
article
|
| 31 |
Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection
|
Munakata, Yasuhiko
|
|
|
106 |
10 |
p. 3449-3456
|
article
|
| 32 |
Leukemia RNAi: harnessing the killer within
|
Zeleznik-Le, Nancy J.
|
|
|
106 |
10 |
p. 3336-3337
|
article
|
| 33 |
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project
|
Bennett, Charles L.
|
|
|
106 |
10 |
p. 3343-3347
|
article
|
| 34 |
MEK kinase 1 activity is required for definitive erythropoiesis in the mouse fetal liver
|
Bonnesen, Barbara
|
|
|
106 |
10 |
p. 3396-3404
|
article
|
| 35 |
Molecular identification of PAL-E, a widely used endothelial-cell marker
|
Niemelä, Harri
|
|
|
106 |
10 |
p. 3405-3409
|
article
|
| 36 |
More flitting about FLT3
|
Litzow, Mark R.
|
|
|
106 |
10 |
p. 3331-3332
|
article
|
| 37 |
MVA-TRICOM vaccine strategy makes CLL cells an attractive T-cell target
|
Byrd, John C.
|
|
|
106 |
10 |
p. 3334-3335
|
article
|
| 38 |
Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guérin (BCG) results in the release of functional soluble TRAIL/Apo-2L
|
Kemp, Troy J.
|
|
|
106 |
10 |
p. 3474-3482
|
article
|
| 39 |
nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse
|
Ohgami, Robert S.
|
|
|
106 |
10 |
p. 3625-3631
|
article
|
| 40 |
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials
|
Gale, Rosemary E.
|
|
|
106 |
10 |
p. 3658-3665
|
article
|
| 41 |
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma
|
Stühmer, Thorsten
|
|
|
106 |
10 |
p. 3609-3617
|
article
|
| 42 |
Novel lentiviral vectors displaying “early-acting cytokines” selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells
|
Verhoeyen, Els
|
|
|
106 |
10 |
p. 3386-3395
|
article
|
| 43 |
PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism
|
Walter, Roland B.
|
|
|
106 |
10 |
p. 3584-3593
|
article
|
| 44 |
Plasmodium falciparum rhoptry protein RSP2 triggers destruction of the erythroid lineage
|
Layez, Corinne
|
|
|
106 |
10 |
p. 3632-3638
|
article
|
| 45 |
Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules
|
Palena, Claudia
|
|
|
106 |
10 |
p. 3515-3523
|
article
|
| 46 |
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype
|
Boissel, Nicolas
|
|
|
106 |
10 |
p. 3618-3620
|
article
|
| 47 |
Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma
|
Dewald, Gordon W.
|
|
|
106 |
10 |
p. 3553-3558
|
article
|
| 48 |
Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)
|
Chanan-Khan, Asher
|
|
|
106 |
10 |
p. 3348-3352
|
article
|
| 49 |
Role of VAD in the initial treatment of multiple myeloma
|
Lane, Steven W.
|
|
|
106 |
10 |
p. 3674
|
article
|
| 50 |
Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma
|
Kundu, Mondira
|
|
|
106 |
10 |
p. 3621-3624
|
article
|
| 51 |
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection
|
Alter, Galit
|
|
|
106 |
10 |
p. 3366-3369
|
article
|
| 52 |
Severe anemia in malaria: defense gone wrong?
|
Winter, Gerhard
|
|
|
106 |
10 |
p. 3337-3338
|
article
|
| 53 |
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
|
Mazodier, Karin
|
|
|
106 |
10 |
p. 3483-3489
|
article
|
| 54 |
Src family kinase–mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets
|
Garcia, Analia
|
|
|
106 |
10 |
p. 3410-3414
|
article
|
| 55 |
Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells
|
Thomas, Maria
|
|
|
106 |
10 |
p. 3559-3566
|
article
|
| 56 |
T-bet is required for optimal proinflammatory CD4+ T-cell trafficking
|
Lord, Graham M.
|
|
|
106 |
10 |
p. 3432-3439
|
article
|
| 57 |
T-bet: the first master regulator for lymphocyte homing commitment?
|
Campbell, James J.
|
|
|
106 |
10 |
p. 3332-3333
|
article
|
| 58 |
The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D–target-cell interactions
|
Sconocchia, Giuseppe
|
|
|
106 |
10 |
p. 3666-3672
|
article
|
| 59 |
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia
|
Levine, Ross L.
|
|
|
106 |
10 |
p. 3377-3379
|
article
|
| 60 |
Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells
|
Sundrud, Mark S.
|
|
|
106 |
10 |
p. 3440-3448
|
article
|
| 61 |
VAD and initial therapy for multiple myeloma
|
Vincent Rajkumar, S.
|
|
|
106 |
10 |
p. 3674-3675
|
article
|
| 62 |
V617F “JAKs” up myeloproliferative signal
|
Tefferi, Ayalew
|
|
|
106 |
10 |
p. 3335-3336
|
article
|
Journal description